<DOC>
	<DOCNO>NCT01415999</DOCNO>
	<brief_summary>Anthracyclines use commonly treat child solid tumour haematological malignancy lead increased survival . Nonetheless , anthracycline side effect cardiotoxicity . The purpose study assess impact anthracycline therapy heart deformation fibrosis , heart-vessel interaction , usefulness circulate biomarkers assessment heart function potential genetic predisposition heart failure adult survivor childhood cancer .</brief_summary>
	<brief_title>Cardiovascular Function Adult Survivors Childhood Malignancies</brief_title>
	<detailed_description>Incorporation anthracyclines chemotherapy protocols improved survival child solid tumour haematological malignancy . Nonetheless , longitudinal study implicate absence safe anthracycline dose free cardiotoxicity . Substantial risk cardiovascular disease show recently large cohort adult survivor childhood adolescent survivor . Serial monitoring cardiac function hence paramount importance childhood cancer survivor early detection myocardial damage timely institution intervention . The optimal monitoring cardiac function long term at-risk patient remain establish . Novel noninvasive imaging modality include echocardiography cardiac magnetic resonance allow interrogation myocardial deformation fibrosis , circulate biomarkers increasingly use monitor cardiac status heart failure patient . Additionally , genetics heart failure increasingly unveiled .</detailed_description>
	<criteria>patient age 18 35 year old history acute leukaemia diagnose 18 year old completion cancer direct therapy least 5 year . history congenital heart disease presence syndromal disorder Down syndrome , neurofibromatosis , etc , hypothyroidism replacement therapy claustrophobia reason render MRI assessment feasible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>anthracycline</keyword>
	<keyword>cardiac function</keyword>
	<keyword>echocardiography</keyword>
	<keyword>biomarkers</keyword>
</DOC>